We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Tomosynthesis Enhances Identification of Infiltrating Ductal Carcinoma in Women at Increased Risk of Breast Cancer

By MedImaging International staff writers
Posted on 02 May 2013
Three-dimensional (3D) mammography, also known as tomosynthesis, is superior at revealing infiltrating ductal carcinoma than 2D mammography in women at increased risk of breast cancer. As part of a new study, six breast-imaging specialists reviewed both 2D and 3D mammography images of 56 tumors detected in patients at intermediate or high risk of breast cancer.

“We found that 41% (23/56 cancers) were better seen on tomosynthesis and 4% (2/56) were only seen on tomosynthesis,” said Dr. Sarah O'Connell, from South Shore Medical Center (Norwell, MA, USA), and a lead author of the study. Thirty percent of tumors (17/56) were better visualized on 2D mammography but none were seen only on 2D mammography. The remaining were gauged by the breast imaging specialists as being equally visible on both 2D and 3D imaging, she reported. “The majority of cancers seen better or only on tomosynthesis were predominantly infiltrating ductal carcinoma, which typically presents as a mass, focal asymmetry, or architectural distortion,” said Dr. O'Connell.

Most of the tumors better seen or only on 2D mammography were ductal carcinoma in situ (DCIS), which present as calcifications, according to Dr. O'Connell. “This was not surprising because tomosynthesis gives us the ability to scroll through the breast tissue in 1-mm sections, which provides us with more detail, but also may separate a cluster of calcifications, making them more difficult to identify,” said Dr. O'Connell. She noted that work is being done to optimize visualization of calcifications on tomosynthesis.

The advantages of tomosynthesis are predominantly pertinent to women at increased risk of breast cancer who have increased concerns about breast screening and have the potential for biologically aggressive cancers, noted Dr. O'Connell.

The study’s findings were presented in April 16, 2013, at the American Roentgen Ray Society (ARRS) annual meeting in Washington DC (USA).

Related Links:
South Shore Medical Center



40/80-Slice CT System
uCT 528
Multi-Use Ultrasound Table
Clinton
High-Precision QA Tool
DEXA Phantom
Ultrasound Table
Women’s Ultrasound EA Table

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.